{"slug":"clinicalintelpulse-theaslangroupllc-com-api-clinical-mechani-8b6e1e","title":"Drug mechanism-of-action + molecular target landscape for any disease — targets ","host":"clinicalintelpulse.theaslangroupllc.com","method":"GET","resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/mechanism-map","category":"other","description":"Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.","price_listed":0.2,"price_asked":0.2,"state":"answering","state_label":"Answering","checks_7d":1,"answered_7d":1,"latency_ms_median":252,"reported_calls_30d":1,"reported_payers_30d":1,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"method":"GET","queryParams":{"condition":"Disease — e.g. \"Treatment-Resistant Depression\" | \"ALS\" | \"Lupus\" | \"Multiple Sclerosis\" | \"Prostate Cancer\"","lang":"en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)","mechanism":"Optional — specific mechanism to focus on, e.g. \"BTK inhibitor\" | \"IL-17\" | \"CAR-T\""},"type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"properties":{"condition":{"type":"string"},"lang":{"type":"string"},"mechanism":{"type":"string"}},"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"errors":{"additionalProperties":{"properties":{"description":{"type":"string"},"example":{"type":"object"}},"required":["description"],"type":"object"},"description":"Documented error responses, keyed by HTTP status code","type":"object"},"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-10-18","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.2,"price_match":true,"latency_ms":252,"error":null}],"description_full":"Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.","last_updated":"2026-10-16T02:44:10.805Z","schemes":["exact"]}